crostube.blogg.se - Poc molecular diagnostics

#POC MOLECULAR DIAGNOSTICS DRIVERS#
#POC MOLECULAR DIAGNOSTICS DRIVER#
#POC MOLECULAR DIAGNOSTICS PORTABLE#
#POC MOLECULAR DIAGNOSTICS FREE#

These factors have led clinical laboratories to find alternative ways to maintain revenue despite limited capacity and testing volumes. Hospitals and diagnostic laboratories are reducing their expenditure on POC molecular diagnostics to have either break even or profitable revenue.The reimbursement policies for diagnostic testing are not constant across various geographies, and they are moving in a downward trend.One of the key challenges to the global POC molecular diagnostics industry growth is the strained laboratory budgets and lowering reimbursements affecting instrument sales.Key POC Molecular Diagnostics Market Challenge Therefore, the burden of extra cost to the end-users in the form of additional tests is reduced along with the ease of detection.These assays are based on the combination of multiplex PCR and biochip array hybridization. RANDOX BIOSCIENCES has come up with Familial Hypercholesterolemia (FH) Arrays I and II, which are rapid, simple, and accurate diagnostics test for the detection of 40 FH-causing mutations (20 mutations per array) within the LDLR, ApoB, and PCSK9 genes.

#POC MOLECULAR DIAGNOSTICS PORTABLE#

This Q-POC is a portable device that provides results within 20 minutes. To increase the efficiency and effectiveness of the results, the companies are developing advanced products.

Growing focus on technological advances is one of the key POC molecular diagnostics market trends that is expected to impact the industry positively in the forecast period.

Key POC Molecular Diagnostics Market Trend

These factors have increased the demand for POC molecular diagnostics, as these instruments assist in disease diagnosis, which will be contributing to market growth.

The elderly require diagnostic testing regularly due to their low immunity and metabolism.

Apart from the impaired functioning of the immune system, the reduced functioning of organs also increases the chances of acquiring infections.

The prevalence of diseases such as lung disease, cancer, and stroke, is high among the aging population.

For instance, in 2020 the growth rate of the geriatric population in Australia was 16% and 20% in France.

The geriatric population is increasing significantly across the world.

The absence of physical activity and improper diet in today's lifestyle has led to major medical problems, especially in the geriatric population.

One of the key factors driving the global POC molecular diagnostics industry growth is the growing geriatric population.

#POC MOLECULAR DIAGNOSTICS DRIVER#

Key POC Molecular Diagnostics Market Driver

#POC MOLECULAR DIAGNOSTICS DRIVERS#

The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the POC molecular diagnostics industry. The growing geriatric population is notably driving the POC molecular diagnostics market growth, although factors such as strained laboratory budgets and lowering reimbursements affecting instrument sales may impede market growth. POC Molecular Diagnostics Market: Key Drivers, Trends, and Challengesīased on our research output, there has been a positive impact on the market growth during and post COVID-19 era.

#POC MOLECULAR DIAGNOSTICS FREE#

What will the POC Molecular Diagnostics Market Size be During the Forecast Period?ĭownload the Free Report Sample to Unlock the POC Molecular Diagnostics Market Size for the Forecast Period and Other Important Statistics Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, and Quidel Corp. Hoffmann La Roche Ltd., genedrive plc, Lucira Health Inc., Molbio Diagnostics Pvt. The POC molecular diagnostics market vendors studied and compiled in this report include Abbott Laboratories, Becton Dickinson and Co., binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. The POC molecular diagnostics market research report extensively covers POC molecular diagnostics market segmentation by product (PCR and microarray and hybridization), application (infectious diseases, oncology, hematology and endocrinology, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). The report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. According to Technavio analysts, the POC molecular diagnostics market share is expected to increase by USD 1.83 billion from 2021 to 2026 at an accelerating CAGR of 14.67%.